Earnings History Data for ADC Therapeutics SA (ADCT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

ADC Therapeutics SA

ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
28-02-2023 PM 7:00 AM ET
(Feb 28)		 ADCT ADC Therapeutics SA 334.67 -0.30 -0.49 -0.45 ADC Therapeutics Non-GAAP EPS of -$0.10 misses by $0.05, revenue of $19.8M misses by $45.69M
[2/28/2023 7:02 AM]		 3.62 -0.45 
(-11.06%)		 3.98 -0.09 
(-2.21%)		 2.69 - 17.28 444,723 300,000 26,293
08-11-2022 PM 7:00 AM ET
(Nov 8)		 ADCT ADC Therapeutics SA 339.31 -0.65 -0.51 -0.93 ADC Therapeutics Non-GAAP EPS of $0.13, revenue of $76.32M
[11/8/2022 7:11 AM]		 4.16 -0.10 
(-2.35%)		 4.60 0.34 
(7.98%)		 4.00 - 29.74 443,688 340,000 22,666
09-08-2022 PM 7:00 AM ET
(Aug 9)		 ADCT ADC Therapeutics SA 565.33 -0.84 -0.96 -0.95 ADC Therapeutics Non-GAAP EPS of -$0.73, revenue of $17.29M misses by $13.93M
[8/9/2022 7:10 AM]		 7.94 -0.11 
(-1.37%)		 8.05 0.0 
(0.00%)		 5.52 - 32.00 196,378 280,000 391
09-05-2022 PM 7:00 AM ET
(May 9)		 ADCT ADC Therapeutics SA 869.49 -0.22 -0.76 -0.67 ADC Therapeutics Non-GAAP EPS of -$0.36, revenue of $46.5M beats by $12.57M
[5/9/2022 7:10 AM]		 7.46 -3.49 
(-31.87%)		 10.95 0.0 
(0.00%)		 7.41 - 32.00 655,749 150,000 203
03-03-2022 PM 7:00 AM ET
(Mar 3)		 ADCT ADC Therapeutics SA 1,280 -0.45 -0.87 -0.73 ADC Therapeutics Non-GAAP EPS of -$0.39 beats by $0.49, revenue of $17.01M beats by $0.54M
[3/3/2022 7:11 AM]		 15.00 -1.22 
(-7.52%)		 17.03 0.81 
(4.99%)		 13.34 - 32.00 177,066 140,000 400
02-11-2021 PM 7:00 AM ET
(Nov 2)		 ADCT ADC Therapeutics SA 2,250 -0.93 -0.97 -0.29 ADC Therapeutics EPS misses by $0.01, beats on revenue
[11/2/2021 7:14 AM]		 29.18 -2.33 
(-7.39%)		 32.50 0.99 
(3.14%)		 20.01 - 38.34 774,913 160,000 1,140
03-08-2021 PM 7:00 AM ET
(Aug 3)		 ADCT ADC Therapeutics SA 1,650 -0.95 -0.84 -0.71 ADC Therapeutics EPS misses by $0.09, beats on revenue
[8/3/2021 7:08 AM]		 22.72 2.01 
(9.68%)		 21.50 0.79 
(3.81%)		 20.01 - 53.35 395,333 220,000 141
06-05-2021 PM 7:00 AM ET
(May 6)		 ADCT ADC Therapeutics SA 1,730 -0.67 1.00 0.00 ADC Therapeutics EPS beats by $0.17
[5/6/2021 7:04 AM]		 22.61 0.61 
(2.77%)		 22.61 0.0 
(0.00%)		 21.16 - 56.59 417,185 540,000 3,038
18-03-2021 PM 7:00 AM ET
(Mar 18)		 ADCT ADC Therapeutics SA 1,920 -0.73 -0.68 0.00 ADC Therapeutics reports Q4 results
[3/18/2021 7:09 AM]		 28.99 -0.41 
(-1.39%)		 29.95 0.55 
(1.87%)		 21.51 - 56.59 572,910 510,000 4,166
12-11-2020 PM 7:15 AM ET
(Nov 12)		 ADCT ADC Therapeutics SA 2,510 -0.29 -0.77 0.00 ADC Therapeutics reports Q3 results
[11/12/2020 7:11 AM]		 34.00 -0.67 
(-1.93%)		 0.0 0.0 
(0.00%)		 25.10 - 56.59 143,002 155,723 0
18-08-2020 PM Before the open
(Aug 18)		 ADCT ADC Therapeutics SA 2,800 -0.71 -0.76 0.00 39.00 0.38 
(0.98%)		 0.0 0.0 
(0.00%)		 28.50 - 56.59 129,400 223,715 0